Insider sale
GRACELL BIOTECHNOLOGIES INC.
$664.7K
116K shares
What this filing means
ORBIMED CAPITAL LLC plans to sell 116K shares of GRACELL BIOTECHNOLOGIES INC. valued at approximately $664.7K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 6/15/2023ACC: 0000947871-23-000682
116K
Shares to sell
$664.7K
Approx. market value
116K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Private placement
Cash
10/14/2020
116KTotal acquired116K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
10/14/2020 | Private placement Cash | 116K | — |
| Total | 116K | ||
Planned & Completed Dispositions1
Nasdaq Stock MarketPlanned
Units to sell
116K
Market value
$664.7K
6/15/2023
Total
Units
116K
Value
$664.7K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
6/15/2023 | 116K | $664.7K | Nasdaq Stock Market | Planned |
| Total | 116K | $664.7K | ||